Diabetes complications

Effect of multifactorial intensive treatment in patients with diabetic kidney disease: A meta‐analysis with trial sequential analysis

Diabetes Obes MetabPublished Systematic review and meta-analysis of randomised trials

Authors' conclusion

The present study suggested that MT had a remarkable benefit on the risk of all-cause mortality and cardiovascular event disease in patients with DKD. Our results were promising, but had certain limitations, which warrants additional large-scale RCTs to validate our findings.

Study context

Population
Patients with diabetic kidney disease (DKD)5 randomized control trials (RCTs)
Comparison
Multifactorial intensive treatment vs control
Outcome
Efficacy and safety of MT
Methodological detailstrial sequential analysis, fixed-effect or random-effect model
  • Trial sequential analysis
  • Fixed-effect or random-effect model

Pooled result

As reported in the abstract

MTHazard ratio (95% CI)P value
All-cause mortality
0.75(0.60–0.93)
P = 0.008
Cardiovascular event disease rate
0.55(0.44–0.68)
P < 0.001

Further pooled results

Retinopathy progression

HR (95% CI)P value
MT0.79 (0.66–0.95)P = 0.011

Progression of macroalbuminuria

HR (95% CI)P value
MT0.64 (0.43–0.95)P = 0.027

Progression of microalbuminuria

HR (95% CI)P value
MT0.69 (0.56–0.86)P = 0.001

Safety

All adverse events

RR (95% CI)P value
MT1.00 (0.97–1.03)P = 0.830

All severe adverse events

RR (95% CI)P value
MTStatistical power confirmed by trial sequential analysis0.92 (0.74–1.15)P = 0.478

Original publication

Effect of multifactorial intensive treatment in patients with diabetic kidney disease: A meta‐analysis with trial sequential analysis. Diabetes Obes Metab. Published 8 May 2023. doi:10.1111/dom.15093

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.